Wednesday - April 29, 2026

Graves’ Ophthalmopathy Market Forecast Analysis 2034: Clinical Trial, Pipeline, FDA Approvals and companies by DelveInsight

Graves’ Ophthalmopathy Market Graves Ophthalmopathy companies Include Novartis, Harbour BioMed, Viridian Therapeutics, Suzhou Suncadia Biopharmaceuticals Co., Ltd., Sling Therapeutics, ValenzaBio, Argenx, HanAll Biopharma, Immunovant Sciences, Novartis, Viridian Therapeutics And Many Others The Graves’ Ophthalmopathy (Thyroid Eye Disease) market was valued … Continue reading

Duchenne Muscular Dystrophy Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Vertex Pharma, Bioleaders Corp., Wave Life Sciences, REGENXBIO

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Duchenne Muscular Dystrophy pipeline constitutes 75+ key companies continuously working towards developing 75+ Duchenne Muscular Dystrophy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and … Continue reading

Lewy Body Dementia Pipeline 2026: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Jazz Pharma, Allergan, Noven Pharma, Takeda Pharma, Eli Lilly, Mallinckrodt Pharma

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Lewy Body Dementia pipeline constitutes key companies continuously working towards developing Lewy Body Dementia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading

Psoriasis Market: Investment-Ready Growth Trends to 2034 – DelveInsight | Sun Pharma, Bristol-Myers Squibb, UCB Biopharma, Affibody AB, Ventyx Biosciences, Aclaris Therapeutics, AbbVie, Novartis

The Key Psoriasis Companies in the market include – UCB Pharma, Novartis, Sun Pharmaceutical/ Almirall, Bausch Health, Boehringer Ingelheim, LEO Pharma, AnaptysBio, Nimbus Lakshmi/Takeda, MoonLake Immunotherapeutics, Can-Fite Biopharma, E-nitiate Biopharmaceuticals, SFA Therapeutics, Rubedo Life Sciences, Inc, and others.   DelveInsight’s … Continue reading

Chronic Rhinosinusitis with Nasal Polyps Clinical Trial Pipeline Gains Momentum: 8+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Chronic Rhinosinusitis with Nasal Polyps Pipeline Insight 2026” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in the Chronic Rhinosinusitis with Nasal Polyps pipeline landscape. It covers the Chronic Rhinosinusitis with Nasal Polyps Pipeline drug profiles, … Continue reading

Cutaneous Squamous Cell Carcinoma Clinical Trial Pipeline Appears Robust With 45+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s, “Cutaneous Squamous Cell Carcinoma Pipeline Insight 2026” report provides comprehensive insights about 45+ companies and 45+ pipeline drugs in Cutaneous Squamous Cell Carcinoma pipeline landscape. It covers the Cutaneous Squamous Cell Carcinoma pipeline drug profiles, including clinical and nonclinical … Continue reading

Atopic Dermatitis Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s “Atopic Dermatitis Pipeline Insight 2026” report provides comprehensive insights about 100+ companies and 120+ pipeline drugs in the Atopic Dermatitis pipeline landscape. It covers the Atopic Dermatitis Pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading

Dry Eye Disease Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s “Dry Eye Disease Pipeline Insight 2026” report provides comprehensive insights about 50+ companies and 60+ pipeline drugs in the Dry Eye Disease pipeline landscape. It covers the Dry Eye Disease pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading

Plaque Psoriasis Treatment Pipeline Shows Strong Momentum as 75+ Pharma Companies in the Race | DelveInsight

DelveInsight’s “Plaque Psoriasis Pipeline Insight 2026” report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Plaque Psoriasis pipeline landscape. It covers the Plaque Psoriasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading

Autosomal Dominant Polycystic Kidney Disease Clinical Trial Pipeline Expands as 13+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Autosomal Dominant Polycystic Kidney Disease Pipeline Insight 2026” report provides comprehensive insights about 13+ companies and 14+ pipeline drugs in the Autosomal Dominant Polycystic Kidney Disease pipeline landscape. It covers the Autosomal Dominant Polycystic Kidney Disease Pipeline drug profiles, … Continue reading